Sequencing hormonal ablation and radiotherapy in prostate cancer: A molecular and therapeutic prespective (Review)

Keyphrases

• Radiotherapy 100%
• Ablation 100%
• Prostate Cancer 100%
• Androgen Ablation 80%
• Apoptosis 60%
• Tumor Cells 40%
• Prostate Cancer Cells 40%
• Prostate Tumor 40%
• Apoptotic Pathway 40%
• Advanced Prostate Cancer 40%
• Therapeutic Modalities 40%
• B-cell Lymphoma 2 (Bcl-2) 20%
• Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 20%
• Clinical Consequences 20%
• Successful Treatment 20%
• Caspase 20%
• Effective Treatment 20%
• Prostate Tumor Cells 20%
• Current Therapeutics 20%
• Cell Sensitivity 20%
• Molecular Processes 20%
• Androgen-independent 20%
• Molecular Parameters 20%
• Prostate Cancer Patients 20%
• Combination Strategy 20%
• Molecular Technology 20%
• Cancer Regression 20%
• Fractionated Therapy 20%
• Regulated Cell Death 20%
• Apoptosis Regulation 20%
• Apoptotic Potential 20%
• Signaling Interactions 20%
• Tumor Cell Survival 20%
• Apoptotic Thresholds 20%
• Potential Optimization 20%

Medicine and Dentistry

• Prostate Cancer 100%
• Radiation Therapy 100%
• Androgen 62%
• Programmed Cell Death 50%
• Tumor Cell 50%
• Prostate Tumor 37%
• Cancer Cell 25%
• Therapeutic Modality 25%
• Cell Death 12%
• Cell Survival 12%
• Cancer Regression 12%
• Caspase 12%
• Effective Treatment 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Prostate Cancer 100%
• Androgen 62%
• Neoplasm 37%
• Prostate Tumor 37%
• Caspase 12%
• Cancer Regression 12%